Skip to main content
. 2020 Nov 12;20:837. doi: 10.1186/s12879-020-05567-6

Table 1.

Demographics of included patients

Variables Total Non-SSI group SSI group p value
N (%) 1046 (100%) 972 (92.9%) 74 (7.1%)
Age, years, median (IQR) 59.0 (52.0–70.0) 62.0 (53.0–70.0) 60.5 (50.0–71.0) 0.841
Gender (%) 0.302
 Male 619 (59.2%) 571 (58.7%) 48 (64.9%)
 Female 427 (40.8%) 401 (41.3%) 26 (35.1%)
BMI, median (IQR) 23.0 (20.3–25.4) 23.0 (20.3–25.2) 23.9 (19.9–26.3) 0.421
Comorbidity (%)
 Diabetes mellitus 128 (12.2%) 115 (11.8%) 13 (17.6%) 0.147
 Hypertension 257 (24.6%) 229 (23.6%) 28 (37.8%) 0.006
 Chronic liver disease 20 (1.9%) 20 (2.1%) 0 (0%) 0.390
 Chronic kidney disease 9(0.9%) 9 (0.9%) 0 (0%) 1.00
 Chronic heart disease 40 (3.8%) 34 (3.5%) 6 (8.1%) 0.057
 Tuberculosis 5 (0.5%) 3 (0.3%) 2 (2.7%) 0.043
 Steroid use 9 (0.9%) 8 (0.8%) 1 (1.4%) 0.485
 Immunosuppressive medication 11 (1.1%) 9 (0.9%) 2 (2.7%) 0.180
Smoking history (%) 0.980
 No 839 (80.2%) 780 (80.2%) 59 (79.7%)
 Former 45 (4.3%) 42 (4.3%) 3 (4.1%)
 Current 162 (15.5%) 150 (15.4%) 12 (16.2%)
Hemoglobin, g/dl (%) 0.183
  ≥ 11 762 (72.8%) 713 (73.4%) 49 (66.2%)
  < 11 284 (27.2%) 259 (26.6%) 25 (33.8%)
Albumin, g/dl (%) < 0.001
  ≥ 3.5 815 (77.9%) 773 (79.5%) 42 (56.8%)
  < 3.5 231 (22.1%) 199 (20.5%) 32 (43.2%)
Blood glucose, mg/dl (%) 0.025
  < 80 181 (17.3%) 168 (17.3%) 13 (17.6%)
 80 ~ 150 771 (73.7%) 723 (74.4%) 48 (64.9%)
  > 150 94 (9.0%) 81 (8.3%) 13 (17.6%)
LPS, day, median (IQR) 6 (3.5–9.0) 6 (3–9) 7.5 (4–9) 0.130

IQR interquartile range, BMI body mass index, LPS Length of preoperative stay